Literature DB >> 9121331

The extent of leprosy-related disabilities in Istanbul Leprosy Hospital, Turkey.

T Cakiner1, A Yüksel, A S Eğït, G Cağri, M Karaçorlu, A Kültür.   

Abstract

This study was carried out between January and December 1992 at the Istanbul Leprosy Hospital. Seven hundred and eleven leprosy patients were evaluated according to their age, gender and type of disease and disability according to the WHO disability grading system (1980). There were 527 males (74.2%) and 184 females (25.8%) in the group. The average age was 50.0 +/- 13.5 years and the average duration of disease was 25.9 +/- 13.2 years. Six hundred and seventy-eight patients (95.4%) were in borderline (BL) and lepromatous (LL) leprosy. The extent of disabilities was very high in 711 leprosy patients. It was found that 539 of the patients (75.8%) had eye disabilities, 511 of them (71.8%) had hand disabilities, 521 of them (73.3%) had foot disabilities. The most frequent eye, hand and foot disabilities were a decrease of vision (52.7), acute or chronic iridocyclitis (48.8%), slightly-marked corneal sensory loss (43.2%), mobile claw hand (33.3%), palmar insensitivity (16.3%), plantar ulcer (37.2%) and plantar insensitivity (19.8%). Eye deformities were the most common of the three affected areas in this study.

Entities:  

Mesh:

Year:  1997        PMID: 9121331     DOI: 10.5935/0305-7518.19970007

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  2 in total

1.  Risk factors for physical disability in patients with leprosy disease in Yunnan, China: Evidence from a retrospective observational study.

Authors:  Xiaohua Chen; Hong-Bing Liu; Tie-Jun Shui; Shun Zha
Journal:  PLoS Negl Trop Dis       Date:  2021-11-10

2.  The burden of physical disability among patients with newly detected leprosy in Yunnan, China, 1990-2020: A population-based, cross-sectional survey.

Authors:  Xiaohua Chen; Tie-Jun Shui
Journal:  PLoS Negl Trop Dis       Date:  2022-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.